Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by Dibah42on Jul 01, 2020 3:09pm
124 Views
Post# 31212950

RE:Nasdaq equity raise??

RE:Nasdaq equity raise??
sah1 wrote: Quite surprised by the Nasdaq action based on minimal news. You have to wonder what the reaction will be when the BLA is actually filed and registered by the FDA and if priority review is given and the Bla finally approved? Will the sp be sustained at US $20+ for the next couple of weeks? If so, I wouldn’t be surprised to see an equity raise of $100M on Nasdaq.



Yup.  I remember the PP @  $3.10 which started the final decline.  CM had to do a major "clean-up"
<< Previous
Bullboard Posts
Next >>